1Hennekam, R.C.M. et al. (1989) Rubinstein–Taybi Syndrome in a mother and son. Eur J Pediatr 148, 439-441
2Marion, R.W., Garcia, D.M., Karasik, J.B. (1993) Apparent dominant transmission of the Rubinstein–Taybi syndrome. Am J Med Genet 46, 284-287
3Petrij, F. et al. (2000) Diagnostic analysis of the Rubinstein–Taybi syndrome: five cosmids should be used for microdeletion detection and low number of protein truncating mutations. J Med Genet 37, 168-76
4Petrij, F. et al. (1995) Rubinstein–Taybi syndrome is caused by mutations in the transcriptional co-activator CBP. Nature 376, 348-351
5Imaizumi, K. and Kuroki, Y. (1991) Rubinstein–Taybi syndrome with de novo reciprocal translocation t(2;16)(p13.3;p13.3). Am J Med Genet 38, 636-639
6Tommerup, N., van der Hagen, C.B. and Heiberg, A. (1991) Tentative assignment of a locus for Rubinstein–Taybi Syndrome to 16p13.3 by a de novo reciprocal translocation, t(7;16)(q34;p13.3). Cytogenet Cell Genet 58, 2002
7Lacombe, D. et al. (1992) Confirmation of assignment of a locus for Rubinstein–Taybi syndrome gene to 16p13.3. Am J Med Genet 44, 126-128
8Breuning, M.H. et al. (1993) Rubinstein–Taybi Syndrome caused by submicroscopic deletions of chromosome 16. Am J Hum Genet 52, 249-54
9Bartsch, O. et al. (2005) DNA sequencing of CREBBP demonstrates mutations in 56% of patients with Rubinstein–Taybi syndrome (RSTS) and in another patient with incomplete RSTS. Hum Genet 117, 485-493
10Roelfsema, J.H. et al. (2005) Genetic Heterogeneity in Rubinstein–Taybi Syndrome: Mutations in Both the CBP and EP300 Genes Cause Disease. Am J Hum Genet 76, 572-580
11Rubinstein, J.H. and Taybi, H. (1963) Broad thumbs and toes and facial abnormalities. A possible mental retardation syndrome. Am J Dis Child 105, 588-608
12Michail, J., Matsoukas, J. and Theodorou, S. (1957) Arched, clubbed thumb in strong abduction-extension & other concomitant symptoms. Rev Chir Orthop Reparatrice Appar Mot 43, 142-146
13Stevens, C.A. and Bhakta, M.G. (1995) Cardiac abnormalities in the Rubinstein-Taybi syndrome. Am J Med Genet 59, 346-348
14Hennekam, R.C.M. et al. (1990) Rubinstein–Taybi syndrome in the Netherlands. Am J Med Genet Suppl. 6, 17-29
15Wiley, S. (2003) Rubinstein-Taybi syndrome medical guidelines. Am J Med Genet 119, 101-110
16Rubinstein, J.H. (1990) Broad thumb-hallux (Rubinstein–Taybi) Syndrome 1957-1988. Am J Med Genet Suppl. 6, 3-16
17Hennekam, R.C.M., Boogaard, M.-J. and Doorne, J.M. (1991) A cephalometric study in Rubinstein–Taybi syndrome. J Craniofac Genet Dev Biol 11, 33-40
18Hennekam, R.C.M. et al. (1990) Metacarpophalangeal pattern profile analysis in Rubinstein–Taybi Syndrome. Am J Med Genet Suppl. 6, 48-50
19Hennekam, R.C. et al. (1993) Deletion at chromosome 16p13.3 as a cause of Rubinstein-Taybi syndrome: clinical aspects. Am J Hum Genet 52, 255-262
20Hennekam, R.C.M. et al. (1992) Psychological and speech studies in Rubinstein–Taybi syndrome. Am J Mental Retard 96, 645-660
21Miller, R.W. and Rubinstein, J.H. (1995) Tumors in Rubinstein–Taybi syndrome. Am J Med Genet 56, 112-115
22Hennekam, R.C.M., Stevens, C.A. and van de Kamp, J.J.P. (1990) Etiology and recurrence risk in Rubinstein–Taybi Syndrome. Am J Med Genet Suppl. 6, 56-64
23Sobel, R.A. and Woerner, S. (1981) Rubinstein–Taybi syndrome and nasopharyngeal rhabdomyosarcoma. J Pediatr 99, 1000-1001
24Bonioli, E. and Bellini, C. (1992) Rubinstein–Taybi Syndrome and pheochromocytoma. Am J Med Genet 44, 386
25Bilir, B.M., Bilir, N. and Wilson, G.N. (1990) Intracranial angioblastic meningioma and an aged appearance in a woman with Rubinstein–Taybi Syndrome. Am J Med Genet Suppl. 6, 69-72
26Cambiaghi, S. et al. (1994) Multiple pilomatricomas in Rubinstein–Taybi syndrome: a case report. Pediatr Dermatol 11, 21-25
27Urlinger, S. et al. (2000) Exploring the sequence space for tetracycline-dependent transcriptional activators: novel mutations yield expanded range and sensitivity. Proc Natl Acad Sci U S A 97, 7963-7968
28Russell, N.A., Hoffman, H.J. and Bain, H.W. (1971) Intraspinal neurilemoma in association with the Rubinstein–Taybi syndrome. Pediatrics 47, 444-447
29Jonas, D.M., Heilbron, D.C. and Ablin, A.R. (1978) Rubinstein–Taybi syndrome and acute leukemia. J Pediatr. 92, 851-852
30Goodfellow, A., Emmerson, R.W. and Calvert, H.T. (1980) Rubinstein–Taybi Syndrome and spontaneous keloids. Clin Exp Dermatol 5, 369-371
31Rohlfing, B., Lewis, K. and Singleton, E.B. (1971) Rubinstein–Taybi syndrome. Report of an unusual case. Am J Dis Child 121, 71-74
32Kwok, R.P. et al. (1994) Nuclear protein CBP is a coactivator for the transcription factor CREB. Nature 370, 223-226
33Lundblad, J.R. et al. (1995) Adenoviral E1A-associated protein p300 as a functional homologue of the transcriptional co-activator CBP. Nature 374, 85-88
34Chrivia, J.C. et al. (1993) Phosphorylated CREB binds specifically to the nuclear protein CBP. Nature 365, 855-859
35Shi, Y. and Mello, C. (1998) A CBP/p300 homolog specifies multiple differentiation pathways in Caenorhabditis elegans. Genes Dev 12, 943-955
36Bordoli, L. et al. (2001) Plant orthologs of p300/CBP: conservation of a core domain in metazoan p300/CBP acetyltransferase-related proteins. Nucleic Acids Res. 29, 589-597
37Giles, R.H., Peters, D.J.M. and Breuning, M.H. (1998) Conjunction dysfunction: CBP/p300 in human disease. Trends Genet. 14, 178-183
38Goodman, R.H. and Smolik, S. (2000) CBP/p300 in cell growth, transformation, and development. Genes Dev 14, 1553-1577
39Bannister, A.J. and Kouzarides, T. (1996) The CBP co-activator is a histone acetyltransferase. Nature 384, 641-643
40Ogryzko, V.V. et al. (1996) The transcriptional coactivators p300 and CBP are histone acetyltransferases. Cell 87, 953-959
41Gu, W. and Roeder, R.G. (1997) Activation of p53 sequence-specific DNA binding by acetylation of the p53 C-terminal domain. Cell 90, 595-606
42Roth, S.Y., Denu, J.M. and Allis, C.D. (2001) Histone acetyltransferases. Annu Rev Biochem 70, 81-120
43Kung, A.L. et al. (2000) Gene dose-dependent control of hematopoiesis and hematologic tumor suppression by CBP. Genes Dev 14, 272-277
44Oike, Y. et al. (1999) Truncated CBP protein leads to classical Rubinstein–Taybi syndrome phenotypes in mice: implications for a dominant-negative mechanism. Hum Mol Genet 8, 387-396
45Tanaka, Y. et al. (2000) Extensive brain hemorrhage and embryonic lethality in a mouse null mutant of CREB-binding protein. Mech Dev 95, 133-145
46Yao, T.P. et al. (1998) Gene dosage-dependent embryonic development and proliferation defects in mice lacking the transcriptional integrator p300. Cell 93, 361-372
47Kalkhoven, E. (2004) CBP and p300: HATs for different occasions. Biochem Pharmacol 68, 1145-1155
48Kasper, L.H. et al. (2006) Conditional knockout mice reveal distinct functions for the global transcriptional coactivators CBP and p300 in T-cell development. Mol Cell Biol 26, 789-809
49Kwok, R.P., Liu, X.T. and Smith, G.D. (2006) Distribution of co-activators CBP and p300 during mouse oocyte and embryo development. Mol Reprod Dev 73, 885-894
50Partanen, A., Motoyama, J. and Hui, C.C. (1999) Developmentally regulated expression of the transcriptional cofactors/histone acetyltransferases CBP and p300 during mouse embryogenesis. Int J Dev Biol 43, 487-494
51Kawasaki, H. et al. (1998) Distinct roles of the co-activators p300 and CBP in retinoic-acid-induced F9-cell differentiation. Nature 393, 284-289
52Ugai, H., Uchida, K., Kawasaki, H. and Yokoyama, K.K. (1999) The coactivators p300 and CBP have different functions during the differentiation of F9 cells. J Mol Med 77, 481-494
53Roth, J.F. et al. (2003) Differential role of p300 and CBP acetyltransferase during myogenesis: p300 acts upstream of MyoD and Myf5. EMBO J 22, 5186-5196
54Tanaka, Y. et al. (1997) Abnormal skeletal patterning in embryos lacking a single Cbp allele: a partial similarity with Rubinstein–Taybi syndrome. Proc Natl Acad Sci U S A 94, 10215-10220
55Bartholdi, D. et al. (2007) Genetic heterogeneity in Rubinstein–Taybi Syndrome: delineation of the phenotype of the first patients carrying mutations in EP300. J Med Genet 44, 327-333
56Petrij, F. et al. (2000) Rubinstein–Taybi syndrome caused by a De Novo reciprocal translocation t(2;16)(q36.3;p13.3). Am J Med Genet 92, 47-52
57Giles, R.H. et al. (1997) Construction of a 1.2-Mb contig surrounding and molecular analysis of, the human CREB-binding protein (CBP/CREBBP) gene on chromosome 16p13.3. Genomics 42, 96-114
58Troke, P.J., Kindle, K.B., Collins, H.M. and Heery, D.M. (2006) MOZ fusion proteins in acute myeloid leukaemia. Biochem Soc Symp 73, 23-39
59Bartsch, O. et al. (2006) Evidence for a new contiguous gene syndrome, the chromosome 16p13.3 deletion syndrome alias severe Rubinstein–Taybi syndrome. Hum Genet 120, 179-186
60Schouten, J.P. et al. (2002) Relative quantification of 40 nucleic acid sequences by multiplex ligation-dependent probe amplification. Nucleic Acids Res 30, e57
61Bentivegna, A. et al. (2006) Rubinstein–Taybi Syndrome: spectrum of CREBBP mutations in Italian patients. BMC Med Genet 7, 77
62Bartsch, O. et al. (1999) FISH studies in 45 patients with Rubinstein–Taybi syndrome: deletions associated with polysplenia, hypoplastic left heart and death in infancy. Eur J Human Genet 7, 748-756
63Coupry, I. et al. (2004) Analysis of CBP (CREBBP) gene deletions in Rubinstein–Taybi syndrome patients using real-time quantitative PCR. Hum Mutat 23, 278-284
64Udaka, T. et al. (2006) Screening for Partial Deletions in the CREBBP Gene in Rubinstein–Taybi Syndrome Patients Using Multiplex PCR/Liquid Chromatography. Genet Test 10, 265-271
65Kalkhoven, E. et al. (2003) Loss of CBP acetyltransferase activity by PHD finger mutations in Rubinstein–Taybi syndrome. Hum Mol Genet 12, 441-450
66Udaka, T. et al. (2005) Comprehensive screening of CREB-binding protein gene mutations among patients with Rubinstein–Taybi syndrome using denaturing high-performance liquid chromatography. Congenit Anom 45, 125-131
67Bartsch, O. et al. (2002) Molecular studies in 10 cases of Rubinstein–Taybi syndrome, including a mild variant showing a missense mutation in codon 1175 of CREBBP. J Med Genet 39, 496-501
68Coupry, I. et al. (2002) Molecular analysis of the CBP gene in 60 patients with Rubinstein–Taybi syndrome. J Med Genet 39, 415-421
69Murata, T. et al. (2001) Defect of histone acetyltransferase activity of the nuclear transcriptional coactivator CBP in Rubinstein–Taybi syndrome. Hum Mol Genet 10, 1071-1076
70Zimmermann, N. et al. (2007) Confirmation of EP300 gene mutations as a rare cause of Rubinstein-Taybi syndrome. Eur J Hum Genet advance online publication 14 February 2007; doi: 10.1038/sj.ejhg.5201791
71Bito, H., Deisseroth, K. and Tsien, R.W. (1996) CREB phosphorylation and dephosphorylation: a Ca(2+)- and stimulus duration-dependent switch for hippocampal gene expression. Cell 87, 1203-1214
72Abel, T. et al. (1997) Genetic demonstration of a role for PKA in the late phase of LTP and in hippocampus-based long-term memory. Cell 88, 615-626
73Atkins, C.M. et al. (1998) The MAPK cascade is required for mammalian associative learning. Nat Neurosci 1, 602-609
74Bourtchouladze, R. et al. (2003) A mouse model of Rubinstein–Taybi syndrome: defective long-term memory is ameliorated by inhibitors of phosphodiesterase 4. Proc Natl Acad Sci U S A 100, 10518-10522
75Wood, M.A. et al. (2006) A transcription factor-binding domain of the coactivator CBP is essential for long-term memory and the expression of specific target genes. Learn Mem 13, 609-617
76Oike, Y. et al. (1999) Mice homozygous for a truncated form of CREB-binding protein exhibit defects in hematopoiesis and vasculo-angiogenesis. Blood 93, 2771-2779
77Alarcon, J.M. et al. (1999) Chromatin acetylation, memory, and LTP are impaired in CBP +/− mice: a model for the cognitive deficit in Rubinstein–Taybi syndrome and its amelioration. Neuron 42, 947-959
78Korzus, E., Rosenfeld, M.G. and Mayford, M. (2004) CBP histone acetyltransferase activity is a critical component of memory consolidation. Neuron 42, 961-972
79Wood, M.A. et al. (2005) Transgenic mice expressing a truncated form of CREB-binding protein (CBP) exhibit deficits in hippocampal synaptic plasticity and memory storage. Learn Mem 12, 111-119
80Josselyn, S.A. (2005) What's right with my mouse model? New insights into the molecular and cellular basis of cognition from mouse models of Rubinstein–Taybi Syndrome. Learn Mem 12, 80-83
81Gayther, S.A. et al. (2000) Mutations truncating the EP300 acetylase in human cancers. Nat Genet 24, 300-303
82Ozdag, H. et al. (2002) Mutation analysis of CBP and PCAF reveals rare inactivating mutations in cancer cell lines but not in primary tumours. Br J Cancer 87, 1162-1165
83Kishimoto, M. et al. (2005) Mutations and deletions of the CBP gene in human lung cancer. Clin Cancer Res 11, 512-519
84Hennekam, R.C. (2006) Rubinstein–Taybi syndrome. Eur J Human Genet 14, 981-985
85Wallerstein, R. et al. (1997) Submicroscopic deletions at 16p13.3 in Rubinstein–Taybi syndrome: frequency and clinical manifestations in a North American population. J Med Genet 34, 203-206
